Centers for Disease Control and Prevention (CDC)
The policies, guidelines, terms, and conditions of the HHS Centers for Disease Control and Prevention (CDC) stated in this funding opportunity announcement (FOA) might differ from those used by the HHS National Institutes of Health (NIH). If written guidance for completing this application is not available on the CDC website, then CDC will direct applicants elsewhere for that information.
National Institute for Occupational Safety and Health (NIOSH)
State Occupational Safety and Health Surveillance Program (U60)
(U60 Research Project – Cooperative Agreements)
Reissue of PAR-14-275
Eligible institutions may only apply for one type of program. See Section III. 3. Additional Information on Eligibility.
NIOSH has established surveillance programs intended to assess the extent and severity of workplace illnesses, injuries, exposures, and fatalities; identify workers and occupations at greatest risk; set program priorities for follow-up activities, including more in-depth data surveillance and outreach, prevention and/ or intervention programs and policies to address state priorities and emerging issues; develop a broad network of partners who can assist in identifying occupational safety and health (OSH) surveillance data and best ways to disseminate results to stakeholders; communicate audience-specific educational materials and other resources for optimizing their uptake and adoption for protecting workers; and measure the effectiveness of prevention activities.
OSH surveillance includes population/group- and case-based approaches and activities. Funded programs are expected to be resourceful and proactive in identifying and accessing untapped data sources for OSH surveillance, which may include creating linkages between data sources.
NIOSH seeks to strengthen OSH surveillance within states and other eligible jurisdictions to provide information that will help drive actions to improve the health of workers in the US. This program will build upon the existing state and local public health capacity and expertise in OSH surveillance, and for states and others where OSH surveillance capacity does not currently exist, this program may help to develop that capacity.
September 24, 2020
September 30, 2020
October 30, 2020; August 10, 2021; August 10, 2022
Special Date: A teleconference call will be conducted on Thursday, October 1, 2020 to address questions from prospective applicants regarding this funding opportunity announcement (FOA). The call will begin at 1:00 PM Eastern Time and end at 2:00 PM Eastern Time, or sooner if all questions are addressed. Submit questions in advance to CAPT Linda West at LKW0@cdc.gov. NIOSH will post a summary of the information provided about 3 weeks after the call.
Participant Access Information
Call Date: Thursday, October 1, 2020
Call Start Time: 1:00 PM Eastern Time
Call End Time: 2:00 PM Eastern Time
Call Leader: Linda West, Scientific Program Official
Toll-Free Number: 1-888-989-6494
Enter: 8979183# when prompted
December 16, 2020; September 14, 2021; September 14, 2022
On-time submission requires that electronic applications be error-free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 5:00 PM Eastern Time on the listed application due date.
Applicant organizations are strongly encouraged to start the registration process at least 4 weeks prior to the application due date
Note: HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window)
September 15, 2022
It is critical that applicants follow the Research (R) Instructions in the SF424 (R&R) Application Guide, except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.
There are several options available to submit your application through Grants.gov to NIH and Department of Health and Human Services partners. You must use one of these submission options to access the application forms for this opportunity.
I. Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission Information
Section V. Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information
This program is described in the Catalog of Federal Domestic Assistance and is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency Review. Awards are made under the authorization of the Occupational Safety and Health Act of 1970, Section 20(a) and 21(a) (29 USC 669(a) and 29 USC 670); Federal Mine Safety and Health Act, Section 501(a), 30 USC 1 (Note), and 30 USC 951(a); and Section 301 of the Public Health Service Act as amended (42 USC 241) and under Federal Regulations 42 CFR Part 52. All awards are subject to 45 CFR Part 75, the terms and conditions, cost principles, and other considerations described in the HHS Grants Policy Statement.
Each year, millions of workers in the United States are injured on the job or become ill as a result of exposure to health hazards at work. In 2018, 5,250 U.S. workers died from occupational injuries according to the Census of Fatal Occupational Injuries Summary. Although deaths from work-related illnesses are more difficult to enumerate, a 2011 publication estimated that 53,445 work-related deaths occur annually.
In 2018 the US Bureau of Labor Statistics indicated that employers reported approximately 2.8 million nonfatal work-related injuries and illnesses to private industry workers. Work-related injuries and illnesses result in substantial human and economic costs for workers, families, employers, and society as a whole. A 2011 publication estimated that the direct and indirect costs of work-related injuries and illnesses exceed $250 billion annually.
Achievements in reducing fatal and nonfatal work-related injuries and illnesses emphasize the importance of continued tracking and monitoring, research, and intervention activities in surveillance. Work-related injuries and illnesses can be prevented, and successful approaches to making workplaces safer and healthier begin with having the data necessary to understand the problem. As part of its mission to prevent work-related injury, illness, disability, and death caused by hazards in the workplace, the U.S. Centers for Disease Control and Prevention (CDC), National Institute for Occupational Safety and Health (NIOSH) conducts surveillance to assess the extent and severity of workplace injury, illness, disability, and death to identify workers and occupations at greatest risk, to develop research and prevention priorities, and to measure the effectiveness of prevention activities.
State Role in Occupational Safety and Health Surveillance
NIOSH recognized the key importance of state public health approaches to addressing occupational health problems and began funding pilot surveillance programs in a limited number of state health departments in the 1970’s. State public health agencies have a critical and complementary role in the prevention of occupational injury, illness, disability and death. State agencies apply public health approaches to identify problems, target interventions, and evaluate programs to reduce occupational illness, injury, disability, and death in order to protect the health of working people. These agencies are uniquely positioned to utilize state-specific data sources and link surveillance findings with intervention outreach activities within their jurisdictions/
Since the inception of funding state-based surveillance programs, NIOSH has funded a variety of approaches to build state capacity in occupational safety and health, ranging from the development of population-based and case-based surveillance systems, to creating focused public health interventions addressing the occupational safety and health needs of high-risk populations such as minorities and teen workers. State programs demonstrate that effective surveillance of occupational injury, illness, disability, and death embraces the concept of “information for action” by ensuring that collection, analysis, interpretation, and dissemination of health data are linked to prevention and control activities. In addition, state surveillance systems and activities provide a vital foundation for several federal surveillance systems and augment others.
NIOSH has used cooperative research agreement funding mechanisms to fund approximately ten state surveillance programs since 2000, and by 2009, the number of funded states increased from 15 to 23. NIOSH has provided financial and technical assistance to state health and labor agencies to develop or expand state surveillance program capacity and technical infrastructure. Examples include addition of epidemiologists and other technical staff, training and continuing education, informatics or methods improvements, contracting for specialized statistical and communications expertise, and purchase of statistical software.
Information on the previous funding opportunity announcement for the current state surveillance program can be found in PAR-14-275. The current 26 state surveillance portfolio of cooperative agreements funded from 2015-2021 consists of 8 Fundamental, 11 Fundamental-Plus, and 7 Expanded Programs. These 26 states contain about 72% of the civilian labor force and include 18 of the 26 most populated states in the US. State surveillance programs are managed by 19 state health departments (73%) 2 state Departments of Labor (8%), and 5 bona fide agents (19%), which involve partnerships between state health departments and universities. The portfolio is comprised of approximately 49 projects addressing work-related morbidity and mortality, exposure reduction, and worker populations of special interest including underserved populations. The NIOSH OEP Web site has more information about the current state surveillance program, highlights from their programs, and information about NIOSH surveillance and other extramural programs by HHS Region.
Intermediate goals specify desired actions on the part of external stakeholders using NIOSH research findings and outputs. Applicants are highly encouraged to read and indicate how NIOSH's strategic plan, which includes NIOSH program intermediate goals, fit within their proposed program. NIOSH has also identified extramural research priority goals for the five-year period of fiscal year 2019 (FY19) to fiscal year 2023 (FY23). Applicants might also be interested to learn about these priorities.
The Council for State and Territorial Epidemiologists (CSTE) created Guidelines for Minimum and Comprehensive State-Based Public Health Activities in Occupational Safety and Health to provide information for all states about strategic and organizational activities to foster and ensure a competent OSH program.
Since the prior state surveillance program competition in 2015, the National Academy of Sciences Engineering and Medicine reviewed NIOSH surveillance activities in 2018 and published a report with recommendations for creating a smarter, national surveillance system for occupational safety and health in the 21st century. It is hereafter referred to as the NAS Report in this announcement.
In 2019, NIOSH collected input from the public using a Request for Information (RFI) published in the Federal Register and a public teleconference meeting on September 16, 2019. In December 2019, NIOSH published its Implementation Plan for addressing the NAS Report recommendations.
NIOSH has used information from the NAS report, the RFI docket, the public meeting, and its implementation plan to guide surveillance activities and strengthen the next phase of the state occupational safety and health surveillance program. NIOSH weighed multiple factors, including: the need for stability and flexibility in the surveillance program, the ability to continue Fundamental, Fundamental-Plus, and Expanded Programs under one funding mechanism, the continued use of Occupational Health Indicators, and the ability to include research and non-research activities under one funding mechanism.
The primary purpose of this Funding Opportunity Announcement (FOA) is to solicit meritorious applications for continuing and expanding state* occupational safety and health surveillance programs (*henceforth referred to as “states;” see Section III for Eligibility Information), with the goal of improving OSH surveillance across the US. NIOSH supports the use of existing surveillance data and the collection of new surveillance data to better define the current health of the state’s workforce, target relevant worker populations at risk, develop relevant interventions, and initiate and enhance partnerships within, and beyond, the state’s surveillance community. NIOSH also supports the advancement of state surveillance systems to enable the future use of new or newly emerging electronic surveillance data sources and to participate in the development of the data sources and data exchange methods. NIOSH strongly encourages state surveillance programs to engage directly in activities and initiatives related to the collection, exchange, and use of electronic health data.
States are expected to be innovative in the dissemination and communication of products that they develop. Whenever possible, communication products must inform measurable surveillance data findings and related public health actions that include recommendations for prevention, interventions, policies, and communications that advance the integration of proven health and safety strategies into targeted workplaces by organizations both within and outside of traditional occupational health.
A key goal is to build partnerships among surveillance programs and health agencies, and other organizations and stakeholders that engage in occupational safety and health surveillance or can be leveraged to further surveillance. Applicants are strongly encouraged to include collaborations that focus on related issues when interests and activities align with other CDC-funded programs. Applicants are equally encouraged to propose collaborations with key organizations including universities, state or federal groups such as the Occupational Safety and Health Administration, Bureau of Labor Statistics, workers’ compensation carriers, and others involved in surveillance, including employers and employers’ groups to strengthen and enhance the impacts of their activities.
Applicants may also consider collaborating with government and public sector organizations (such as Tribal Nations and the Department of Transportation) that are not typically associated with occupational safety and health surveillance but whose programs may impact worker safety and health. Finally, applicants should strongly consider or continue collaborations with other NIOSH funded research Centers such as Education and Research Centers (ERCs), Centers for Agricultural Safety and Health (Ag Centers), Centers of Excellence for Total Worker Health®, and Training Project Grants. Such relationships, once established, may also benefit recipients by further enhancing their activities. These programs are described in greater detail on the NIOSH OEP Web site.
Proposed goals and objectives should be clearly stated in the application and directly linked to the occupational health and safety burdens being addressed. Applicants are expected to justify their proposal by describing the burden of the problem, the need for the proposed research or activity, and the potential for impact or likelihood of success.
Applicants should provide data to support their selection of proposed work, such as morbidity or mortality rates, indicators of the size of the population at risk (including estimates of the target population's potential risk of exposure to the hazard, frequency of exposure, or sociodemographic factors such as age, gender, and race/ethnicity). Similarly, applicants may provide qualitative data and/or information that describe exposures, the magnitude of the problem, and potential benefits and impacts of addressing the issue. Qualitative data and/or information may be necessary when the nature of the exposure or population at risk make collecting large-scale, representative quantitative data difficult.
Governmental agencies and organizations have been faced with increasing demand to measure the effectiveness in improving research and/or public health practice activities. Effectiveness can be measured by the products (outputs) of program activities and subsequent outcomes, such as benefits or changes at an individual or population level. Outputs are the immediate products or direct result of program activities. Examples include publications, reports, conference proceedings, presentations/posters, investigator career development, databases, tools, methods, guidelines, recommendations, education and training materials.
The causes of work-related injuries and illnesses are complex and determining the effect that program activities have on them can take years. Thus, outcomes can be measured over time as either intermediate or end outcomes.
Intermediate outcomes are specific changes that occur as a result of program activities. Examples of intermediate outcomes include public or private policy changes, conduct of training or workshops based on project outputs, citations in the literature, inventions and patents, and adoption of technologies or methods developed by the applicant.
End outcomes are the goal of the program activities and the result of what individuals or institutions do with the knowledge or products generated by program activities. Examples of end outcomes include reduction in workplace illnesses, injuries, fatalities, and/or hazardous exposures.
Note to Applicants
Provide a brief statement about expected outputs and outcomes of the proposed activities in the Project Summary and in the Research Strategy (Significance).
Occupational safety and health priorities and relevant Healthy People 2020 Objectives are primarily addressed through the National Occupational Research Agenda (NORA). Now in its third decade (2016–2026), NORA focuses on occupational safety and health in 10 industry sectors based on major areas of the U.S. economy and 7 health and safety cross-sectors organized according to the major health and safety issues affecting the U.S. working population. The national agenda is developed and implemented through the NORA Sector and Cross-Sector Councils. Each council develops and maintains an agenda for its sector or cross-sector. The collection of agendas comprises the agenda for the nation for improvements in occupational safety and health. In addition, NIOSH is interested in monitoring changes in the workforce, work organization factors, and emerging issues in OSH. For example, in recent years states have served in meaningful investigational, educational, and outreach roles for work related to opioids, cannabinoids, respiratory health (silicosis), and infectious disease clusters or events, such as COVID-19. In the future, this could include COVID-19 vaccination information.
Looking forward, Healthy People 2030 is the fifth edition of Healthy People. It aims at new challenges and builds on lessons learned from its first 4 decades. HHS has approved the Healthy People 2030 framework which is based on recommendations made by the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030.
NIOSH expects work conducted under this FOA to:
Worker health surveillance at NIOSH is conducted across Divisions and Programs under the overarching structure of the NIOSH Surveillance Program. The Surveillance Program contributes to the NIOSH goal of improving worker safety and health by producing actionable information on workplace injuries, illnesses, hazards, exposures, and deaths in the United States. In addition to implementing surveillance systems for cases of occupational injuries and illnesses, NIOSH makes use of both secondary data and novel data sources for surveillance, such as adding an occupational health module to the National Health Interview Survey (NHIS) and establishing a virtual center for workers’ compensation studies to explore opportunities for use of workers compensation data for surveillance.
NIOSH actively partners with the states in surveillance and epidemiology to develop goals, jointly conduct and/or coordinate programmatic activity, share surveillance data and research statistics, and communicate national and regional major accomplishments and impact. In cooperation with state programs, NIOSH co-publishes numerous surveillance and epidemiology articles related to OSH exposures and illnesses in order to highlight work being done by the recipients. NIOSH makes these and other state outputs publicly available through the State-based Occupational Health Surveillance Clearinghouse. NIOSH also collaborates with the Council of State and Territorial Epidemiologists (CSTE) to increase state-based surveillance capacity in the US. With NIOSH support, CSTE develops and maintains Occupational Health Indicator methods and data; develops guidance, success stories, and communication strategies; integrates surveillance into broader public health practice; coordinates and plans meetings, workshops, and webinars for state surveillance practitioners; and promotes collaboration between and across state and federal government.
Goals of the NIOSH State Surveillance Program include:
NIOSH uses Burden, Need and Impact (BNI) to identify and define priorities for the work of NIOSH. Applicants are expected to utilize this framework to describe their proposed activities.
Burden may be defined as risks from exposure to work-related hazards; occurrence of injuries, illnesses, exposures, and deaths due to work-related factors; and broad economic and social impacts, including wellbeing. The extent of exposure can be assessed in terms of the number of workers exposed, the severity of the exposure, or both. The assessment of burden is based on several main constructs: the magnitude of the problem; health impact severity; exposure to workers; societal costs; new or emerging issues; and relationship to work environment. For emerging issues, the burden will be anticipatory burden. Applicants should estimate the potential burden using the same arguments for existing burden, identify any assumptions, and provide a rationale for extrapolating potential burden to the population at risk.
Need helps define the gap in surveillance activities that the applicant's proposed work will help to fill. For identifying priorities, need helps to contextualize the burden. Applicants should identify areas where surveillance and linked public health action are most needed (gaps). Applicants should describe how they are the best entity to address this aspect of burden.
Impact is a measure of the potential contributions of the program to worker health and safety based on evident or anticipated end outcomes or well-accepted intermediate outcomes. Potential impact is expressed as potential reduction in burden or increase in intervention effectiveness. Some examples may include use of project outputs by peers and stakeholders; changes in stakeholder policies and procedures, practices, or behavior; follow-up research or activities that resulted from the current program; invited presentations from peer and stakeholder groups; further dissemination of project outputs by stakeholders; and scientific awards or recognition by professional organizations. The assessment of potential impact is based on the potential of the proposed program to result in knowledge, policy, interventions, technologies, or solutions to occupational health problems.
Overview of Programs
Applicants may apply for one of the following three types of programs: 1) Fundamental, 2) Fundamental-Plus, or 3) Expanded.
Applicants not previously funded by NIOSH for a state-based surveillance program are encouraged to consider applying for a Fundamental Program.
Applicants previously funded for a Fundamental Program, and other applicants with established capacity to conduct fundamental activities, are encouraged to consider applying for a Fundamental-Plus Program.
Applicants for an Expanded Program are expected to have extensive demonstrated experience in conducting surveillance, field investigations (as applicable), establishing partnerships and collaborations, and carrying out effective prevention and intervention activities following from surveillance findings.
Each applicant should carefully evaluate their capacity to conduct the activities described under each program type and apply for only one of these programs.
Table 1. Required Contents for State Surveillance Program Applications
All applications must include the following fundamental activities
Health Informatics - NNDSS, BRFSS, RCKMS, other (new data sources)
Communication and Translation Plan
Partnerships and Collaboration Plan
Addressing Underserved Populations (underserved worker groups)
Evaluation and Performance Management Plan
Fundamental-Plus Program applications must also include these 2 types of Projects:
Expanded Program applications must include the fundamental activities listed above with the following enhancements AND up to 4 Expanded Projects.
In-depth analyses of OSH conditions, exposures or worker populations using existing state data sets, and/or new case findings and case follow-up. These results may be used by states to develop, recommend or implement, and evaluate intervention and prevention activities.
Policies and procedures for performing case follow-back of selected condition(s) or working populations of special interest, including methods for identifying associated worksites.
Describe a system to enable the identification of the relevant occupational illnesses, injuries, fatalities, or exposures.
Establish electronic access or linkages to data source(s) for surveillance, including the use or development of tools, applications, or processes that increase the availability, accessibility, and timeliness of data.
Communication and Translation Plan
Implement descriptive plans for targeted activities suggested by surveillance data and information. This may include promoting the use of data by others for intervention or establishing working relationships with other agencies for case or work site referral.
Partnerships and Collaboration Plan
Collaborate with NIOSH and other participating states on projects related to a specific priority condition, population, or exposure.
Participate actively in relevant CDC/NIOSH- and recipient-convened meetings or conference calls of grantees to share experiences and best practices on topics such as emerging trends, hazards, and data challenges and solutions, given your additional experience in OSH surveillance.
Expanded Program Projects in OSH Surveillance (up to 4 priority areas)
Acronyms used in Table 1 and related information
OHI: Occupational Health Indicators
NNDSS: National Notifiable Disease Surveillance System
BRFSS: CDC Behavioral Risk Factor Surveillance System
RCKMS: Reportable Conditions Knowledge Management System
OSH: Occupational Safety and Health
FACE: Fatality Assessment Control and Evaluation
ORDS: Occupational Respiratory Disease Surveillance
ABLES: (NIOSH Adult Blood Lead Epidemiology Surveillance System)
Fundamental Programs establish and maintain "fundamental” occupational safety and health surveillance capacity and conduct all fundamental activities detailed below. Fundamental programs are expected to provide a basic level of program activity and work to establish or build program capacity.
Fundamental Programs will conduct the following activities:
Use available data sources (use the Current Population Survey (CPS) if able) to generate an employment profile of the employed workers in the state. Guidance on generating the employment profile is provided in this Guidance Manual.
Collect, analyze, and interpret a minimum of 15 of 24 Occupational Health Indicators (OHIs) annually and submit to specified contacts. All programs must generate the following 10 indicators:
If data for one or more of these 10 OHIs listed above is not accessible, an OHI of the program's choice may be substituted. Applicants should clearly explain the rationale for their choice(s).
Programs may choose an additional 5 OHIs (for a minimum of 15 OHIs) based on availability of data and state priorities. Detailed guidance for generating all 24 OHIs is available on the CSTE Web page. Identify and document the utility and any limitations (e.g., lack of reliable denominators, incomplete data, and lack of uniformity or consistency) of existing data needed to generate OHIs.
Use OHIs to identify and prioritize the state’s occupational health burden and needs and conduct follow-up prevention activities such as investigations, interventions, or policy/rule changes for high priority issues in their state.
Participate in the NIOSH Adult Blood Lead Epidemiology Surveillance System (ABLES) to conduct annual follow-back/intervention/communication activities for work-related adult blood lead cases based on case load. Programs with a case load of greater than 1,000 cases of Adult Blood Lead Levels (BLLs) of 10µg/dL or higher may request up to an additional $20,000. Programs with a case load between 300 and 1,000 such cases may request up to an additional $10,000. Programs with a case load of fewer than 300 such cases may request up to an additional $5,000.
NIOSH also supports the advancement of state surveillance systems to enable the future use of new or newly emerging electronic surveillance data sources and to participate in the development of the data sources and data exchange methods. NIOSH strongly encourages state surveillance programs to engage directly in activities and initiatives related to the collection, exchange, and use of electronic health data through the activities described below.
Communication and Translation Plan
The purpose of the Communication and Translation Plan is to identify intended audiences and stakeholders for dissemination of surveillance findings and tailor communication products to those groups. Findings that might be communicated could be the following: public health impact an economic burden of work-related illnesses and mortality, how and why surveillance data informs policy/legislation, advance and inform best practices in surveillance and epidemiology, contribution to workplace solutions, or total worker health protection and promotion, such as interaction of occupational and personal risk factors for worker health and safety.
Partnerships and Collaboration Plan
The purpose of the Partnerships and Collaboration Plan is to build and maintain meaningful, productive collaborations and partnerships that will improve state surveillance activities. Partners often add expertise or specialized experience to the program team, which contributes to the success of the overall project, by allowing for more efficient use of existing resources and exchange of information between experts working in various areas of public health and other sectors. Partners can also help surveillance programs implement program strategies and sustain outcomes.
Addressing Underserved Populations (underserved worker groups)
Occupational safety and health surveillance has been limited for worker populations including youth, older workers, non-English speaking workers, immigrant workers, temporary workers, “gig”/online platform workers, other independent contract workers, and workers in high-risk industries or occupations.
Evaluation and Performance Management Plan
The purpose of the Evaluation and Performance Management Plan is to perform basic or targeted evaluation of the surveillance program including measurements commensurate with their level of NIOSH funding, appropriate accessible data sources, and other administrative or feasibility considerations. The overall evaluation goal is for continuous quality improvement of the program.
Fundamental-Plus Programs develop and maintain fundamental occupational safety and health surveillance capacity by conducting all fundamental activities listed above, plus conduct two additional surveillance activities referred to as Fundamental-Plus Project for proposed in-depth work.
Fundamental-Plus programs conduct all fundamental activities described above PLUS add the following two types of projects:
Previous Fundamental-Plus Projects include developing a system to track heat-related illness and fatalities; conducting a pesticide education and intervention program; conducting an analysis of workers’ compensation data; conducting illness and injury interventions for low wage, immigrant, minority, and precarious workers; multi-state collaboration for analysis and dissemination of surveillance data; developing and validating a regional indicator (OHI) for agricultural injuries; and using state syndromic surveillance systems to identify occupational injuries, illnesses, or exposures. An issue that will soon be emerging are aspects of COVID-19 exposures and the impact of efforts to prevent or address these exposures, including vaccinations.
Expanded Programs conduct the highest levels of program activity and possess the highest program capacity. Expanded Programs conduct all Fundamental Activities and conducts in-depth surveillance activities in up to 4 priority areas of their choosing (referred to as Expanded Projects).
Expanded Programs are expected to identify and access data beyond those available from national occupational safety and health surveillance systems and to articulate the need for proposed activities for each proposed priority area.
Expanded Programs require demonstrated experience in conducting occupational safety and health (OSH) surveillance, a robust OSH surveillance program, and an established track record.
Expanded Program applications must include the fundamental activities listed above along with the following enhancements AND up to 4 Expanded Projects:
Communication and Translation Plan
Partnerships and Collaboration Plan
Expanded Program Projects
NIOSH encourages Expanded Program applicants to consider state-specific priority areas, NIOSH extramural research priority areas, or NIOSH Legacy programs for Expanded Projects in occupational safety and health surveillance. State-specific priority areas may be existing or emerging issues of importance to the state: occupational health outcomes, hazards or exposures, occupations/worker populations, or industry sectors that the applicant identifies as having a significant occupational safety and health burden or unmet need.
Applicants may propose Expanded Projects that are exclusively either state or NIOSH priority areas, NIOSH Legacy programs (described below), OR a combination of these. Applicants must clearly explain their rationale for selecting each Expanded Project and as appropriate explain how the combination of projects are inter-connected. Expanded Program Projects involve more in-depth data collection and analysis, case-findings and case follow-up, and identifying or assembling new data sources for OSH surveillance.
NIOSH priorities for state surveillance continue to include outcomes for which NIOSH has existing, highly successful state-federal collaborative surveillance programs. These include legacy programs such as surveillance of injuries and illnesses from pesticide exposure, occupational lung diseases, work-related fatalities through the Fatality Assessment and Control Evaluation (FACE) program, and other NIOSH-state collaborations such as inclusion of industry and occupation questions in state Behavioral Risk Factor Surveillance System (BRFSS).
Along with “traditional” occupational safety and health foci, NIOSH is interested in projects related to identification of occupation/industry in infectious disease reporting, surveillance of opioids and cannabinoids by industry or occupation, injuries and illnesses associated with emerging robotics technologies in the workplace, inclusion of industry and occupation in non-occupational surveillance systems, and other topics of emerging public health importance that attempt to integrate occupational safety and health surveillance and other public health domains (for example, communicable disease and injury). Expanded Projects may also include innovative ideas or solutions to issues, including the use of advanced health informatics to conduct surveillance and address emerging issues such as COVID-19; see more information below about these potential projects.
NIOSH is also interested in work that advances NIOSH priority goals for extramural research for the period FY2019-FY2023. NIOSH Sector and Cross-Sector Programs have identified priority goals for extramural research to fill research gaps that are currently not being addressed by NIOSH intramural or internal research. Applicants are encouraged to identify priority goals for extramural research as part of their Expanded Program Projects.
Health Informatics as Expanded Projects
NIOSH recognizes the need to deploy health information technology (IT) to enhance and expand occupational safety and health surveillance. While NIOSH recognizes that much of this work, such as the development of standards for including work information in electronic health records, is conducted at the federal level, states may wish to propose work in priority areas related to the use of health informatics. NIOSH is interested in funding Expanded Projects to conduct work in areas such as, but not limited to the following:
NIOSH Legacy State Surveillance Programs for Expanded Projects
This guidance is provided for states who seek funding for a project in one of the following NIOSH Legacy State Surveillance Programs: Fatality Assessment and Control Evaluation (FACE), Pesticide Illness & Injury Surveillance, and Occupational Respiratory Disease Surveillance.
These “legacy” surveillance projects have well-developed guidelines and protocols for components such as case definition, case ascertainment, and how to investigate and conduct investigations. Grantees are typically asked to attend and budget for an annual face-to-face program meeting for each priority area they work on. Technical assistance to each program is provided by a designated NIOSH subject matter expert.
Fatality Assessment and Control Evaluation (FACE)
State FACE programs conduct in-depth on-site investigations of select traumatic occupational fatalities in order to discover causes and contributors to the fatalities and develop and disseminate information about prevention. Applicants proposing a FACE program should provide a detailed description of how they will perform the following:
Pesticide Illness and Injury Surveillance
Using a model for surveillance developed by the NIOSH Sentinel Event Notification System for Occupational Risks (SENSOR), state pesticide illness and injury surveillance programs collect data on acute pesticide poisonings to identify outbreaks and emerging pesticide exposures of concern. Applicants proposing a pesticides program should provide a detailed description of how they will:
Occupational Respiratory Disease Surveillance
State based surveillance for occupational lung disease is informed by the NIOSH SENSOR model, which provides case definitions and other guidelines for surveillance of conditions such as work-related asthma and silicosis. States have used a variety of data sources to collect information on occupational respiratory disease surveillance practicing both case-based and population-based surveillance. Applicants proposing a pesticides program should provide a detailed description of how they will:
Cooperative Agreement: A support mechanism used when there will be substantial Federal scientific or programmatic involvement. Substantial involvement means that, after award, CDC scientific or program staff will assist, guide, coordinate, or participate in project activities. See Section VI.2 for additional information about the substantial involvement for this FOA.
The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this FOA.
Not Allowed: Only accepting applications that do not propose clinical trials.
NIOSH intends to commit over a 5-year period about $40M in total costs (direct and indirect) to fund about 30 applications. In 2021, NIOSH seeks to fund up to 8 Fundamental, 13 Fundamental-Plus, and 9 Expanded Programs.
Awards issued under this announcement are contingent upon availability of funds, submission of a sufficient number of meritorious applications, and NIOSH programmatic considerations. Because the nature and scope of the proposed Programs will vary from application to application, it is also anticipated that the size and duration of each award may also vary. The total amount awarded, and the number of awards, will depend on the number, quality, duration, and cost of the applications received.
NIOSH estimates that:
For FY2021 awards, a five-year project period will span 7-1-2021 to 6-30-2026.
Throughout the project period, CDC's commitment to continuation of awards will be conditional on the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the Federal government.
HHS grants policies as described in the HHS Grants Policy Statement will apply to the applications submitted and awards made from this FOA.
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for CDC/NIOSH support as Public or Private Institutions of Higher Education:
o Hispanic-serving Institutions
o Historically Black Colleges and Universities (HBCUs)
o Tribally Controlled Colleges and Universities (TCCUs)
o Alaska Native and Native Hawaiian Serving Institutions
o Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)
Nonprofits Other Than Institutions of Higher Education
Bona Fide Agents: A Bona Fide Agent is an agency/organization identified by the state as eligible to apply under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms" when submitting via www.grants.gov.
Federally Funded Research and Development Centers (FFRDCs): FFRDCs are operated, managed, and/or administered by a university or consortium of universities, other not-for-profit or nonprofit organization, or an industrial firm, as an autonomous organization or as an identifiable separate operating unit of a parent organization. A FFRDC meets some special long-term research or development need which cannot be met as effectively by an agency's existing in-house or contractor resources. FFRDC's enable agencies to use private sector resources to accomplish tasks that are integral to the mission and operation of the sponsoring agency. Click here for more information on FFRDCs.
Non-domestic (non-U.S.) Entities (Foreign Institutions) are
not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
For this announcement, applicants may not include collaborators or consultants from foreign institutions. All applicable federal laws and policies apply.
Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.
Program Directors/Principal Investigators (PD(s)/PI(s))
All PD(s)/PI(s) must have an eRA Commons account. PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.
Any eligible individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for CDC/NIOSH support.
Proposed PD(s)/PI(s) must have the appropriate academic credentials and possess experience in conducting public health surveillance in a health department, bona fide agent, tribal nation, or other such organization. It is not required for a PD/PI to have a terminal degree (such as a MD or PhD), nor an exhaustive list of publications to be a successful PD/PI. Candidates are encouraged to provide examples of experience using public health surveillance data and forming and growing collaborations and partnerships to make a difference in public health, such as public health interventions, and changes in policy and behaviors.
For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.
For institutions/organizations proposing multiple PDs/PIs, NIOSH requires one PD/PI be designated as the "Contact" PI, who will be responsible for all communications between the PDs/PIs and NIOSH, for assembling the application materials outlined below; for leading and managing activities such as scientific, technical, reporting, and research protections which also should be reflected in his/her time commitment in the application. The Contact PD/PI must meet all eligibility requirements for PD/PI status in the same way as other PDs/PIs. A biographical sketch or other support document is required
NOTE: The CDC does not make awards to individuals directly.
This FOA does not require cost sharing as defined in the HHS Grants Policy Statement.
Applicant organizations may only apply for one type of program (Fundamental, Fundamental-Plus, or Expanded). As defined in the HHS Grants Policy Statement, applications received in response to the same funding opportunity announcement generally are scored individually and then ranked with other applications under peer review in their order of relative programmatic, technical, or scientific merit.
CDC/NIOSH will not accept duplicate or highly overlapping applications under review at the same time. This means that the CDC/NIOSH will not accept:
In addition, NIOSH will not accept any application that is essentially the same as one previously reviewed. Resubmission applications may be submitted, according to the Policy on Resubmission Applications from the SF424 (R&R) Application Guide but must include an Introduction addressing the previous peer review critique (Summary Statement).
Applications that exceed the period of performance limit or the total cost per year (including consortium F&A costs) of the proposed Program type (Fundamental, Fundamental-Plus, or Expanded) will be considered nonresponsive and will not be reviewed. In these cases, CDC/NIOSH will notify the applicant and request that the application be withdrawn.
Regarding page limitations, applicants are encouraged to refer to Section IV. Application and Submission Information, Page Limitations, Tables 2 and 3.
Upon receipt, applications will be evaluated for completeness by NIH/CSR and CDC/NIOSH. CDC/NIOSH will screen all applications for responsiveness. Incomplete or non-responsive applications will not be reviewed. Applicants will be requested to withdraw non-responsive applications.
The SF424 R&R application forms package specific to this opportunity must be accessed through ASSIST, Grants.gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants.gov Workspace are available in Part 1 of this FOA.
If you experience problems accessing or using ASSIST, you can refer to the ASSIST online Help Site at: https://era.nih.gov/erahelp/assist. Additional support is available from the NIH eRA Service Desk via:
• E-mail: http://grants.nih.gov/support/index.html.
• Phone: 301-402-7469 or (toll-free) 1-866-504-9552.
The NIH eRA Service desk is available Monday-Friday, 7 a.m. to 8 p.m. Eastern Time, excluding federal holidays.
If access to the Internet is not available or if the applicant encounters difficulty accessing the forms on-line, contact the CDC Procurement and Grants Office Technical Information Management Section (PGO TIMS) staff at (770) 488-2700 or firstname.lastname@example.org for further instructions. Hours: Monday-Friday, 7 a.m. to 4:30 p.m. Eastern Time.
CDC Telecommunications for the hearing impaired or disabled is available at: TTY 1-888-232-6348.
See your administrative office for instructions if you plan to use an institutional system-to-system solution.
It is critical that applicants follow the Research (R) Instructions in the SF424 (R&R) Application Guide, including Supplemental Grant Application Instructions, except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
The forms package associated with this FOA includes all applicable components, mandatory and optional. Please note that some components marked optional in the application package are required for submission of applications for this FOA. Follow the instructions in the SF 424 (R&R) Application Guide to ensure you complete all appropriate “optional” components.
In conjunction with the SF424 (R&R) components, CDC grants applicants should also complete and submit additional components titled “PHS398.” Note the PHS398 should include assurances and certifications, additional data required by the agency for a complete application. While these are not identical to the PHS398 application form pages, the PHS398 reference is used to distinguish these additional data requirements from the data collected in the SF424 (R&R) components. A complete application to CDC will include SF424 (R&R) and PHS398 components. These forms can be downloaded from https://grants.nih.gov/grants/forms.htm.
For information on Application Submission and Receipt, visit Frequently Asked Questions – Application Guide, Electronic Submission of Grant Applications.
The information requested in a letter of intent allows IC staff to estimate the review workload potential and better plan the review.
By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:
The letter of intent should be sent to:
Michael Goldcamp, PhD
Scientific Review Official
National Institute for Occupational Safety and Health (NIOSH)
Centers for Disease Control and Prevention (CDC)
All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed with the following exceptions or additional requirements:
Table 2. Application Type and Page Limits
Page Limit (maximum pages allowed)
Fundamental Program (FP) Application
New: 14 Renewal: 17
Specific Aims of FP
New & Renewal: 1
Fundamental-Plus Program (FPP) Application
Program Strategy (Includes Program and the 2 Projects)
New: 16 Renewal: 19 (includes Projects)
Specific Aims of FPP (includes Program & Projects)
New & Renewals: 3
Expanded Program (EP) Plan Application
New: 20 Renewal: 25
Specific Aims of EP (includes Program and Projects)
New & Renewals: 6
Expanded Project Plan (up to 4 each)
New: 15 (for each project)
Renewals: 20 (for each project)
Table 3. Section of Application Page Limits
Section of Application
Page Limits (maximum)
5 pages for each Investigator
10 pdf files or 100 pages
A complete application has many components, both required and optional. The forms package associated with this FOA in Grants.gov includes all applicable components for this FOA, required and optional. The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing an application to this FOA.
All instructions in the SF424 (R&R) Application Guide must be followed.
All instructions in the SF424 (R&R) Application Guide must be followed.
All instructions in the SF424 (R&R) Application Guide must be followed. Information covered by this form includes Human Subjects Involvement, Project Summary, Project Narrative, Bibliography and Reference Citations, Facilities and Other Resources (Environment), and Equipment.
For Item 12. Other Attachments, follow the instructions in this FOA to upload the following documents ensuring that the files are clearly named:
All instructions in the SF424 (R&R) Application Guide must be followed.
All instructions in the SF424 (R&R) Application Guide must be followed. Information covered by this form includes Biosketches and Current/Pending Other Support for Project Directors, Principal Investigators, Senior and Key Persons.
All instructions in the SF424 (R&R) Application Guide must be followed. For this FOA, CDC/NIOSH requires a detailed budget for the initial budget year and a budget for each consecutive year of support; this is required for all three program types.
For the "L. Budget Justification" section:
Fundamental Program applicants will upload one PDF with the budget justification for their fundamental program activities.
Fundamental-Plus Program applicants will upload one PDF with budget justifications for fundamental program activities and each fundamental-plus project. Each budget justification should be clearly separated and labeled (headings may be used).
Expanded Program applicants will upload one PDF with budget justifications for their enhanced fundamental program activities and each expanded project. Each budget justification should be clearly separated and labeled (headings may be used).
Applicants should include funds in their annual budgets for two representatives (including the PI or designee) to attend two NIOSH-convened partner meetings per year, which may be virtual or in person. These one-day meetings will be organized and convened by NIOSH with input from grantees and other partners. One meeting will be held each November-December, usually in conjunction with the CSTE Occupational Health Subcommittee meeting. The other meeting will likely coincide with the CSTE Annual Conference (typically in June) when grantees attend the occupational safety and health sessions at the CSTE Conference. For budget purposes, applicant may assume that the November-December meeting will be held in Washington D.C. and the June meeting in Denver, CO.
In addition, applicants for a FACE program must budget for up to two personnel to attend a two-day annual meeting. Applicants for a pesticide illness related project should also budget for one person to attend an annual one and one-half day meeting. Applicants for a work-related lung/respiratory project are also expected to attend an annual 2.5-day meeting for up to two people. For budget preparation, applicants may assume that these meetings will be in Washington D.C. unless specified otherwise.
Note for budget preparation: An applicant may not propose use of grant funds to host and expend funds for a rented venue for a regional or multi-state scientific meeting or conference without a prior approval from CDC/NIOSH.
All instructions in the SF424 (R&R) Application Guide must be followed.
All instructions in the SF424 (R&R) Application Guide must be followed. This form is optional.
All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions: The SF424 (R&R) Application Guide includes instructions for applicants to complete a PHS 398 Research Plan. Not all components of the Research Plan apply to all Funding Opportunity Announcements (FOAs). Specifically, some of the following components are for Resubmissions or Revisions only. See the SF 424 (R&R) Application Guide for additional information. Please attach applicable sections covered by this form as directed.
Follow the page limits stated in the SF 424 (R&R) unless otherwise specified in this FOA. As applicable to and specified in this FOA, the application should include the bolded headers in this section and should address activities to be conducted over the course of the entire project.
The varied nature of state surveillance programs, activities, and projects can involve research and non-research activities. Applicants will use the PHS 398 Research Plan Form to provide information on proposed programs, activities, and projects. Applicants are directed to be clear about research and public health practice activities in the descriptions they provide. Applicants may demonstrate commitment by allocating sufficient staff to the proposed work.
1. Introduction to Application (required only for resubmission applications). Summarize substantial additions, deletions, and changes to the application. Respond to the issues and criticism raised in the summary statement. See specific instructions on the content of the introduction on the NIH Resubmission Applications page.
Note: The Research Plan Section is comprised of Specific Aims, Research Strategy, and Progress Report Publication List.
2. Specific Aims (required for all 3 program types). Provide a clear description about the purpose of the proposed programs, projects, and activities and how they address the specific requirements of this FOA. Describe the programs, activities, projects, and research (if applicable); the problems that they will address; and how they will result in OSH impacts and improvements in worker health.
3. Research Strategy. This section will be used to describe the Program Strategy for each program type.
Significance (include BNI and Outputs and Outcomes here)
Health Informatics - NNDSS, BRFSS, RCKMS, other (new data sources)
Communication and Translation Plan*
Partnerships and Collaboration Plan*
Underserved Populations (underserved worker groups)
Evaluation and Performance Management Plan*
*these plans can be referenced here and uploaded as clearly named files to Item 12. Other Attachments as noted above.
Where research is involved in these activities, include research strategy that addresses Significance, Innovation, and Approach. If research is not involved, please state that clearly.
Fundamental-Plus applications should follow the outline and guidance above.
For each Fundamental-Plus Project (in-depth follow-back assessment and policy/intervention)
provide a Project Strategy that addresses the specific aims, significance, innovation, and approach. BNI can be included under significance. Senior/key persons should be identified. Biosketches are provided elsewhere. Where research is involved, include your strategy and address significance, innovation, and approach. If research is not involved, please state that clearly.
Fundamental-Plus Project Strategies should be clearly named and uploaded to Item 12. Other Attachments, as noted above.
Expanded Program applications should follow the outline above AND include the enhanced Science, Health Informatics, Communication, Translation, Partnership, and Collaboration activities specified in this FOA.
For each Expanded Program Project (up to 4) provide a Project Strategy that addresses the specific aims, significance, innovation, and approach. BNI can be included under significance. Senior/key persons should be identified. Biosketches are provided elsewhere. Where research is involved, include your strategy and address significance, innovation, and approach. If research is not involved, please state that clearly.
Expanded Program Project Strategies should be clearly named and uploaded to Item 12. Other Attachments, as noted above.
Note: Page limits are identified in this Section (above) under "Page Limitations" in Tables 2 and 3.
4. Progress Report Publication List (for Renewal applications only)
Other Research Plan Section
5. Vertebrate Animals (Not Applicable)
6. Select Agent Research (Not Applicable)
7. Multiple PD/PI Leadership Plan
8. Consortium/Contractual Arrangements
9. Letters of Support
10. Resource Sharing Plan(s)
11. Authentication of Key Biological and/or Chemical Resources (Not Applicable)
Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide. Only limited appendix materials are allowed. Do not use the appendix to circumvent page limits.
Resource Sharing Plan: Individuals are required to comply with the instructions for the Resource Sharing Plans as provided in the SF424 (R&R) Application Guide. All applications must address a Data Sharing Plan.
NIOSH considers the sharing of unique data and other research resources developed through the state surveillance occupational safety and health surveillance program an important means to enhance the value and further the advancement of current and future research.
Applicants must include a plan for sharing research resources and data or explain why such sharing is not possible. The precise content of the plan will vary, depending on the data being collected and how the investigator is planning to share the data. Factors to consider include the expected schedule for data sharing, the format of the final dataset, supporting documentation, and whether analytic tools will be provided. Other considerations include whether a data sharing agreement will be required, whether any conditions will be placed on their use, and the mode of data sharing.
Information on data/resource sharing can be found on page II-74 (Sharing Research Tools) of the current HHS Grants Policy.
HHS/CDC policy requires that grant award recipients make unique research resources and data readily available for research purposes to qualified individuals within the scientific community after publication. Individuals are required to comply with the instructions for the Resource Sharing Plans (Data Sharing Plan; Sharing Model Organisms; and Genome Wide Association Studies [GWAS]), as provided in the SF424 (R&R) Application Guide.
Data Management Plan (DMP): CDC requires awardees for projects and programs that involve data collection or generation of data with federal funds to develop and submit a Data Management Plan (DMP) for each collection of public health data.
If applicable, include a DMP in the Resource Sharing Plan section of the PHS 398 Research Plan Component of the application for each proposed collection of public health data. If the public health data to be collected or created are not appropriate for release, provided a concise rationale or justification in the DMP.
The DMP may be outlined in a narrative format or as a checklist but, at a minimum, should include:
CDC Additional Requirement (AR)-25 outlines the components of a DMP and provides additional information for investigators about the requirements for data accessibility, storage, and preservation. The DMP should be developed during the project planning phase, prior to the initiation of collecting or generating public health data and be submitted with the application.
Applications that do not comply with these instructions may be delayed or not accepted for review. Applications submitted without a required DMP may be deemed ineligible for award unless it is clearly stated why a detailed DMP is deferred to a later date and when it will be provided. In these cases, funding restrictions may be imposed on an award until the DMP is submitted and evaluated.
NOTE TO APPLICANTS: This FOA does not allow clinical trials.
The Revised Common Rule defined clinical trial as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. Including behavioral health-related outcomes recognized that clinical trials may occur outside a biomedical context.
When involving human subjects research, clinical research, and/or NIH-defined clinical trials (and when applicable, clinical trials research experience) follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the SF424 (R&R) Application Guide, with the following additional instructions:
If you answered “Yes” to the question “Are Human Subjects Involved?” on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or Delayed Onset Study record.
Study Record: PHS Human Subjects and Clinical Trials Information
All instructions in the SF424 (R&R) Application Guide must be followed.
Delayed Onset Study
All instructions in the SF424 (R&R) Application Guide must be followed.
Note: Delayed onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start).
See Part 2. Section III.1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and Grants.gov
Part I. Overview Information contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday, the application deadline is automatically extended to the next business day.
Organizations must submit applications to Grants.gov (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration. NIH and Grants.gov systems check the application against many of the application instructions upon submission. Errors must be corrected, and a changed/corrected application must be submitted to Grants.gov on or before the application due date and time. If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Policy on Late Application Submission.
Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.
Information on the submission process and a definition of on-time submission are provided in the SF424 (R&R) Application Guide.
This initiative is not subject to intergovernmental review.
All CDC/NIOSH awards are subject to the federal regulations, 45 CFR Part 75, terms and conditions, and other requirements described in the HHS Grants Policy Statement. Pre-award costs may be allowable as an expanded authority, but only if authorized by CDC. For more information on expanded authority and pre-award costs, go to the HHS Grants Policy Statement.
In accordance with the United States Protecting Life in Global Health Assistance policy, all non-governmental organization (NGO) applicants acknowledge that foreign NGOs that receive funds provided through this award, either as a prime recipient or subrecipient, are strictly prohibited, regardless of the source of funds, from performing abortions as a method of family planning or engaging in any activity that promotes abortion as a method of family planning, or to provide financial support to any other foreign non-governmental organization that conducts such activities. See Additional Requirement (AR)-35 for applicability.
CDC requires that mechanisms for, and cost of, public health data sharing be included in grants, cooperative agreements, and contracts. The cost of sharing or archiving public health data may also be included as part of the total budget requested for first-time or continuation awards.
Fulfilling the data-sharing requirement must be documented in a Data Management Plan (DMP) that is developed during the project planning phase prior to the initiation of generating or collecting public health data and must be included in the Resource Sharing Plan(s) section of the PHS398 Research Plan Component of the application. Applicants who contend that the public health data they collect or create are not appropriate for release must justify that contention in the DMP submitted with their application for CDC funds (for example, privacy and confidentiality considerations, and embargo issues).
Awardees who fail to release public health data in a timely fashion will be subject to procedures normally used to address lack of compliance (for example, reduction in funding, restriction of funds, or award termination) consistent with 45 CFR 74.62 or other authorities as appropriate. For further information, please see revised AR-25.
Awards may be initially issued with restrictions until all information requested can be provided. Generally, funds will not be given for renovation of existing facilities or for purchasing substantial amounts of equipment. Funds relating to the conduct of human subjects' research will be restricted until the appropriate assurances and Institutional Review Board approvals are in place.
NOTE TO APPLICANTS: THIS IS REQUIRED
CDC is required to conduct pre-award risk assessments to determine the risk an applicant poses to meeting federal programmatic and administrative requirements by considering issues such as financial instability, insufficient management systems, non-compliance with award conditions, the charging of unallowable costs, and inexperience.
The risk assessment will include an evaluation of the applicant’s CDC Risk Questionnaire, and a review of the applicant’s history in all available systems; including OMB-designated repositories of government-wide eligibility and financial integrity systems (see 45 CFR 75.205(a)), and other sources of historical information. These systems include, but are not limited to: FAPIIS, including past performance on federal contracts as per Duncan Hunter National Defense Authorization Act of 2009; Do Not Pay list; and System for Award Management (SAM) exclusions.
This questionnaire, along with supporting documentation must be submitted with your application by the closing date of this FOA. Upload the questionnaire and supporting documents as an attachment in the "12. Other Attachments" section of the "R&R Other Project Information" section of the application.
If your organization has completed CDC’s Risk Questionnaire within the past 12 months of the closing date of this FOA, then you must submit a copy of that questionnaire, or submit a letter signed by the authorized organization representative to include the original submission date, organization’s EIN and DUNS. When uploading supporting documentation for the Risk Questionnaire into this application package, clearly label the documents for easy identification of the type of documentation. For example, a copy of Procurement policy submitted in response to the questionnaire may be labeled using the following format: Risk Questionnaire Supporting Documents _ Procurement Policy.
Note: CDC requires all applicants to complete the Risk Questionnaire, OMB Control Number 0920-1132 annually.
Applicants are responsible for reporting if this application will result in programmatic, budgetary, or commitment overlap with another application or award (i.e. grant, cooperative agreement, or contract) submitted to another funding source in the same fiscal year. Programmatic overlap occurs when (1) substantially the same project is proposed in more than one application or is submitted to two or more funding sources for review and funding consideration or (2) a specific objective and the project design for accomplishing the objective are the same or closely related in two or more applications or awards, regardless of the funding source. Budgetary overlap occurs when duplicate or equivalent budgetary items (e.g., equipment, salaries) are requested in an application but already are provided by another source. Commitment overlap occurs when an individual’s time commitment exceeds 100 percent, whether or not salary support is requested in the application. Overlap, whether programmatic, budgetary, or commitment of an individual’s effort greater than 100 percent, is not permitted. Any overlap will be resolved by the CDC with the applicant and the PD/PI prior to award.
Report Submission: The applicant must upload the report as an attachment in the "12. Other Attachments" section of the "R&R Other Project Information" section of the application. The document should be labeled: "Report on Programmatic, Budgetary, and Commitment Overlap.”
Applications must be submitted electronically following the instructions described in the SF424 (R&R) Application Guide. Paper applications will not be accepted.
Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.
For assistance with your electronic application or for more information on the electronic submission process, visit How to Apply – Application Guide. If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Dealing with System Issues guidance. For assistance with application submission, contact the Application Submission Contacts in Section VII.
All PD(s)/PI(s) must include their eRA Commons ID in the Credential field of the Senior/Key Person Profile Component of the SF424(R&R) Application Package. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to CDC/NIOSH. See Section III of this FOA for information on registration requirements.
The applicant organization must ensure that the DUNS number it provides on the application is the same number used in the organization’s profile in the eRA Commons and for the System for Award Management. Additional information may be found in the SF424 (R&R) Application Guide.
If the applicant has an FWA number, enter the 8-digit number. Do not enter the letters “FWA” before the number.
If a Project/Performance Site is engaged in research involving human subjects, the applicant organization is responsible for ensuring that the Project/Performance Site operates under and appropriate Federal Wide Assurance for the protection of human subjects and complies with 45 CFR Part 46 and other CDC human subject related policies described in Part II of the SF 424 (R&R) Application Guide and in the HHS Grants Policy Statement.
See more tips for avoiding common errors and submitting, tracking, and viewing applications:
Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the CDC/NIOSH. Applications that are incomplete or non-compliant will not be reviewed.
To expedite review, applicants are requested to notify the CDC/NIOSH Scientific Review Official by email at MGoldcamp@cdc.gov when the application has been submitted. Please include the FOA number and title, PD/PI name, and title of the application.
Applicants are required to follow the instructions for post-submission materials, as described in the policy. Any instructions provided here are in addition to the instructions in the policy.
Only the review criteria described below will be considered in the review process. As part of the CDC mission, all applications submitted to the CDC in support of public health research are evaluated for scientific and technical merit through the CDC peer review system. In addition, as part of the NIOSH mission, all applications submitted to NIOSH in support of occupational safety and health research are
Reviewers will provide an overall impact score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).
Reviewers will consider each of the review criteria below in the determination of scientific merit and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project that by its nature is not innovative may be essential to advance a field.
Reviewers will assess and score the following criteria as appropriate for the type of program (or project) being proposed. Reviewers should use the guidance provided as appropriate for assessing the type of application they are reviewing (Fundamental Program, Fundamental-Plus Program, Expanded Program, or Expanded Program Project).
For Fundamental and Fundamental-Plus programs, reviewers will apply the following criteria to the fundamental activities identified in each application. The final impact score for these activities will be assigned to the application.
For each project proposed in a Fundamental-Plus Program application, reviewers will provide comments but will not assign impact scores.
For Expanded Program applications, reviewers will apply the following criteria to the enhanced fundamental activities proposed. The final impact score for these activities will be assigned to the application.
For each project proposed in an Expanded Program application, reviewers will apply the following criteria. The score for each project will be provided in the summary statement.
Does the applicant provide enough information on the use of relevant, available, and accessible data for assessing the burden of occupational illnesses, injuries, exposures, or fatalities in their state or region? Does the applicant identify critical industries, underserved worker groups, or other at-risk industry or occupation groups? Are the number of workers exposed or at risk described or discussed? Are the number and types of illnesses, exposures, injuries, or deaths have occurred? Are trends for new or emerging burden described? Does the application address a high burden in a specific geographic region? Does the applicant provide relevant, available, and accessible data about elevated incidence and/or prevalence rates provided for illnesses, injuries, exposures, or fatalities, as compared to national, regional, or other state estimates, if known?
Does the application address a burden in a sector(s) or cross sector(s) that would have a significant economic consequence if that burden is not addressed? Have the most relevant indicators been selected?
Does the application address issues of worker populations for whom occupational safety and health surveillance is limited?
Is there a general statement of need for the occupational safety and health surveillance program and how the proposed work fills a current gap(s) in occupational safety and health surveillance for the state?) Is there evidence that the program proposal will address a knowledge gap? Are important state occupational problem(s) or critical barriers addressed?
Does the application identify the areas where surveillance and linked public health action are needed most? Does the applicant adequately describe how emerging issues or hazards will be anticipated and handled? Is the proposed methodology (such as data analyses, interventions, and translation) well-defined and appropriate to the type of program proposed? Is the proposed work feasible? Is this the best time for undertaking this program? Does this proposal address an explicit stakeholder need?
Does the application describe the potential to reduce burden and be successful in generating knowledge or products that will be used by stakeholders? Are intermediate outcomes described that might result in reduced burden or improved health and well-being in the near- or long-term? Is it clear who will benefit from the proposed program (or project)? Are appropriate partners or stakeholders involved for the successful transfer of the findings to the end users or intended audience? Are appropriate impacts identified?
If successful, will the program have the potential to be used in setting standards, guidance, policy, or recommendations? Is there discussion of how the proposed outcomes could be adopted by manufacturers, trade associations, or others? Is there the potential for dissemination of research results by external organizations? Is there potential for others to adopt technology, training programs/materials, intervention strategies, or new surveillance methods used in or resulting from the proposed program (or project)? Is there a potential for technology to be transferred into the marketplace? Is there the potential for program (or project) activities to be scalable or adaptable to reach "at-risk" worker population(s)?
Is there potential for partners to assist in tracking progress of translation efforts? Have relevant partnerships needed to set the stage for impact been described and documented?
Is there potential for this program to be influential in that it will lead others to investigate the problem, open new areas or topics of surveillance research, or improve the scientific approach or public health practice?
Do the PDs/PIs have the skills, knowledge, and resources necessary to carry out the proposed program or project activities? Do the proposed PD(s)/PI(s) have the appropriate academic credentials and possess experience in conducting public health surveillance in a health department, bona fide agent, tribal nation, or other such organization? It is not required for a PD/PI to have a terminal degree (such as a MD or PhD), nor an extensive list of publications to be a successful PD/PI. However, if research is proposed, does the PD/PI have the appropriate experience and expertise in proposed methodologies or populations described in the approach?
Does the application contain examples of how the PD(s)/PI(s) have used public health surveillance data and developed and grew collaborations and partnerships to make a difference in public health, such as public health interventions; public health communications (including dissemination, outreach, and training); and changes in policy and behaviors? Does the application contain biographical sketches or other support documents for each of the PD(s)/PI(s)? Is a Contact PD/PI designated for the Program and Projects proposed, if more than one PD/PI is proposed?
If multiple PDs and PIs are proposed, do the key personnel investigators have complementary and integrated expertise and does the program have appropriate leadership approach, governance, and organizational structure? Does the application identify how each of the PD(s)/PI(s) will be responsible for leading and managing activities such as scientific, technical, reporting, and research protections (if appropriate)? Does application reflect how the time commitment will be allocated for each PD(s)/PI(s) per the program?
Will the applicant test or use new tools or methods to acquire, review, and evaluate occupational safety and health data in order to better understand the incidence, prevalence, and prevention of occupational injuries, illnesses, exposures, or deaths?
Is a refinement, improvement, or new applications of concept or approaches proposed? Does the proposal challenge and seek to shift current occupational safety and health, public health practice, or workplace practice paradigms by using new concepts, approaches, instrumental, or interventions? Does the program (or project) address a recognized critical barrier to progress in the field or take unique or significant advantage of the results from a recent project?
Do specific project activities utilize new or improved methodologies, address novel populations, and/or implement novel approaches to information dissemination?
Are new strategies proposed for programs (or projects) that minimize the time for data acquisition, release of data, data incompatibility, or technologies or systems for interface with programs-specific data? Are there opportunities for collecting new data or incentive for collaboration with external data stewards?
Are the strategy, methodology, and analyses well-reasoned and appropriate for accomplishing the specific aims of the program? Are potential problems, alternative strategies, and benchmarks for success presented? If the program or project is in the early stages of development, will the strategy establish feasibility, and will risky aspects be managed? Does the applicant describe how they plan to access data for surveillance from identified data sources or collaborations? If data linkages are required, as described in the application, does the applicant describe how they will accomplish the linkages? If critical barriers to accessing data for surveillance are identified, has the applicant adequately described how the barriers will be addressed?
If the aims of the program and project are achieved, how will surveillance be improved? How will successful completion of the aims possibly enhance concepts, methods, technologies, interventions or policies that drive this field? Does the applicant propose using evidence-based interventions or strategies in the program or project? Are outcomes and outputs identified and are measures/metrics that will be used to assess outcomes included? Does the application describe how the results from surveillance findings will be disseminated and ultimately used? Is there an evaluation plan and is it adequate?
Does the applicant describe how proposed collaborations across agencies, agency departments, universities, and other organizations will improve worker safety and health by preventing illnesses, injuries, exposures, and fatalities? Does the applicant describe how they will partner with other public health programs or other state agencies to integrate occupational safety and health into their programmatic activity? Are partnerships with other NIOSH-funded entities (Agriculture Centers, Total Worker Health Centers, Education and Research Centers, or Training Project Grants in the state or the region? Are appropriate partners identified and are their roles well defined?
Does the applicant adequately describe how surveillance findings will be communicated and disseminated to stakeholders? Does the applicant adequately describe the use of electronic means of communication, social media, or other contemporary means of communicating (if available to the applicant) to reach workers, employers, public health and other stakeholders in the state?
Does the applicant describe the composition of the advisory committee and how the group will function to give input on issues and priorities? Does the applicant adequately describe how the membership can change to reflect emerging issues and priorities, such that members may rotate on and off as needed by the applicant in order to best utilize the expertise and guidance of the members?
If the program activities involve human subjects, is there an appropriate plan for protection of human subjects from research risks and is any plan for inclusion of minorities, members of both sexes/genders, or children justified in terms of the program or project goals and strategy proposed?
Human Subjects Research and IRB Determinations: Does the applicant describe how their institution makes the determination of whether which activities within their program or project meets or does not meet the definition of human subjects' research? An overview of their process and who or what body/group makes those decisions, if multiple steps are involved, must be described. It is the applicant's responsibility to ensure their process is adequately defined and justified; if it isn't, it could adversely affect an applicant's score.
Will the program (or project) work environment and organizational capacity, such as staff, institutional support, equipment, and other physical resources available to the PD(s)/PI(s), contribute to the probability of success of the program (or project) proposed? Are these resources adequate and will they benefit the program (or project) proposed? Has the applicant described goals for developing program (or project) capacity over the five-year funding period?
Does the applicant provide evidence of their capacity to conduct routine descriptive analyses of data to evaluate its quality and completeness, and identify and prioritize surveillance issues in their jurisdiction? Does the applicant provide evidence of surveillance capacity to respond to requests for technical assistance from other programs and decision makers? Does the applicant provide evidence of using public health surveillance data for prevention efforts?
Will the program (or project) benefit from unique features of the scientific environment, public health approach, or subject population?
As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact score, but will not give separate scores for these items.
For research that involves human subjects but does not involve one of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits to the subjects and others, 4) importance of the knowledge to be gained, and 5) data and safety monitoring for clinical trials.
For research that involves human subjects and meets the criteria for one or more of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: 1) the justification for the exemption, 2) human subjects involvement and characteristics, and 3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Guidelines for the Review of Human Subjects.
When the proposed project involves human subjects and/or NIH-defined clinical research, the committee will evaluate the proposed plans for the inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, and the inclusion (or exclusion) of individuals of all ages (including children and older adults) to determine if it is justified in terms of the scientific goals and research strategy proposed. For additional information on review of the Inclusion section, please refer to the Guidelines for the Review of Inclusion in Clinical Research.
The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following criteria: (1) description of proposed procedures involving animals, including species, strains, ages, sex, and total number to be used; (2) justifications for the use of animals versus alternative models and for the appropriateness of the species proposed; (3) interventions to minimize discomfort, distress, pain and injury; and (4) justification for euthanasia method if NOT consistent with the AVMA Guidelines for the Euthanasia of Animals. Reviewers will assess the use of chimpanzees as they would any other application proposing the use of vertebrate animals. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section.
Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.
For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.
For Renewals, the committee will consider the progress made in the last funding period.
For Revisions, the committee will consider the appropriateness of the proposed expansion of the scope of the project. If the Revision application relates to a specific line of investigation presented in the original application that was not recommended for approval by the committee, then the committee will consider whether the responses to comments from the previous scientific review group are adequate and whether substantial changes are clear.
Dual Use Research of Concern
Reviewers will identify whether the project involves one of the agents or toxins described in the US Government Policy for the Institutional Oversight of Life Sciences Dual Use Research of Concern, and, if so, whether the applicant has identified an IRE to assess the project for DURC potential and develop mitigation strategies if needed.
For more information about this Policy and other policies regarding dual use research of concern, visit the U.S. Government Science, Safety, Security (S3) website at: http://www.phe.gov/s3/dualuse. Tools and guidance for assessing DURC potential may be found at: http://www.phe.gov/s3/dualuse/Documents/durc-companion-guide.pdf.
As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact score.
Outcomes and Outputs
Reviewers will assess whether the applicant has provided enough information about the expected outcomes and outputs of the proposal and how the Program will impact the field of occupational safety and health.
Applications from Foreign Organizations
Select Agent Research
Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).
Resource Sharing Plans
HHS/CDC policy requires that recipients of grant awards make research resources and data readily available for research purposes to qualified individuals within the scientific community after publication. Please see AR-25.
NIOSH considers the sharing of unique data and other research resources developed through the State Occupational Safety and Health Surveillance Program an important means to enhance the value and further the advancement of current and future research.
The reasonableness of the resource sharing plan, or the rationale for not sharing research data, will be assessed by the reviewers. The reviewers will not, however, factor the proposed plan into the determination of scientific merit or the impact score.
Reviewers will comment on whether the following Resource Sharing Plans, or the rationale for not sharing the following types of resources, are reasonable: (1) Data Sharing Plan; (2) Sharing Model Organisms; and (3) Genomic Data Sharing Plan (GDS).
CDC requires recipients for projects and programs that involve data collection or generation of data with federal funds to develop and submit a Data Management Plan (DMP) for each collection of public health data.
Investigators responding to this announcement should include a detailed DMP in the Resource Sharing Plan(s) section of the PHS 398 Research Plan Component of the application. The AR-25 outlines the components of a DMP and provides additional information for investigators regarding the requirements for data accessibility, storage, and preservation.
The DMP should be developed during the project planning phase prior to the initiation of collecting or generating public health data and will be submitted with the application. The submitted DMP will be evaluated for completeness and quality at the time of submission.
The DMP may be outlined in a narrative format or as a checklist but, at a minimum, should include: 1) descriptions of the data to be produced in the proposed project; 2) how access will be provided to the data (including provisions for protection of privacy, confidentiality, security, intellectual property, or other rights); 3) use of data standards that ensure all released data have appropriate documentation that describes the method of collection, what the data represent, and potential limitations for use; and 4) plans for archival and long-term preservation of the data, or explaining why long-term preservation and access cannot be justified.
Authentication of Key Biological and/or Chemical Resources
For projects involving key biological and/or chemical resources, reviewers will comment on the brief plans proposed for identifying and ensuring the validity of those resources.
Budget and Period of Support
Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research. The applicant can obtain guidance for completing a detailed justified budget on the CDC website, at the following Internet address: http://www.cdc.gov/grants/interestedinapplying/applicationresources.html.
Applications submitted in response to this FOA will be evaluated for scientific, technical and educational merit by (an) appropriate Scientific Review Group(s) convened by CDC/NIOSH, in accordance with CDC peer review policy and procedures, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.
As part of the scientific peer review, all applications:
Following initial peer review, a NIOSH Secondary Review Committee will provide a second level of review for programmatic relevance and balance.
The following will be considered in making funding decisions about the proposed occupational safety and health surveillance programs:
The NIOSH Secondary Review Committee will consider applications for funding based on the program type and the projects proposed.
Applications submitted in response to this funding opportunity will compete for available funds with all other recommended applications.
After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons. Refer to Part 1 for dates for peer review, advisory council review, and earliest start date.
Information regarding the disposition of applications is available in the HHS Grants Policy Statement.
If the application is under consideration for funding, HHS/CDC/NIOSH will request "just-in-time" information from the applicant as described in the HHS Grants Policy Statement.
A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization for successful applications. The NoA signed by the grants management officer is the authorizing document and will be sent via email to the grantee’s business official.
Awardees must comply with any funding restrictions described in Section IV.6. Funding Restrictions. Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs.
Any application awarded in response to this FOA will be subject to terms and conditions found on the CDC Office of Financial Resources website. This includes any recent legislation and policy applicable to awards that is highlighted on this website.
Although the financial plans of the HHS/CDC CIO(s) provide support for this program, awards pursuant to this funding opportunity depend upon the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.
Institutional Review Board or Independent Ethics Committee Approval: Grantee institutions must ensure that protocols are reviewed by their IRB or IEC. To help ensure the safety of participants enrolled in CDC-funded studies, the awardee must provide CDC copies of documents related to all major changes in the status of ongoing protocols. For multi-site research, please see NIH Single IRB Policy.
Expanded Authorities: Any award resulting from an application under this FOA is for research and CDC has automatically waived the prior approvals listed in 45 CFR 75.308(d) (1) through (3). In accordance with HHS regulation and CDC guidance, the awardee will have Expanded Authorities including for post award prior approvals, except for the following three Expanded Authorities: 1) human and animal welfare requirements, 2) acquisition of equipment, and 3) change of principal investigator.
All HHS/CDC grant and cooperative agreement awards include the HHS Grants Policy Statement as part of the NoA. For these terms of award, see the HHS Grants Policy Statement and CDC Administrative Requirements (policies) found on the CDC Office of Financial Resources, Grant, webpage.
Recipients of federal financial assistance (FFA) from HHS must administer their programs in compliance with federal civil rights law. This means that recipients of HHS funds must ensure equal access to their programs without regard to a person’s race, color, national origin, disability, age and, in some circumstances, sex and religion. This includes ensuring your programs are accessible to persons with limited English proficiency. HHS recognizes that research projects are often limited in scope for many reasons that are nondiscriminatory, such as the principal investigator’s scientific interest, funding limitations, recruitment requirements, and other considerations. Thus, criteria in research protocols that target or exclude certain populations are warranted where nondiscriminatory justifications establish that such criteria are appropriate with respect to the health or safety of the subjects, the scientific study design, or the purpose of the research.
For additional guidance regarding how the provisions apply to CDC grant programs, please contact the Scientific/Research Contact that is identified in Section VII under Agency Contacts of this FOA. HHS provides general guidance to recipients of FFA on meeting their legal obligation to take reasonable steps to provide meaningful access to their programs by persons with limited English Proficiency. The HHS Office for Civil Rights also provides guidance on complying with civil rights laws enforced by HHS. Please visit here and here for more information. Recipients of FFA also have specific legal obligations for serving qualified individuals with disabilities. Please contact the HHS Office for Civil Rights for more information about obligations and prohibitions under federal civil rights laws here or call 1-800-368-1019 or TDD 1-800-537-7697. Also note it is an HHS Departmental goal to ensure access to quality, culturally competent care, including long-term services and supports, for vulnerable populations. For further guidance on providing culturally and linguistically appropriate services, recipients should review the National Standards for Culturally and Linguistically Appropriate Services in Health and Health Care here.
Prior to making a Federal award, CDC is required by 31 U.S.C. 3321 and 41 U.S.C. 2313 to review information available through any OMB-designated repositories of government-wide eligibility qualification or financial integrity information as appropriate. See also suspension and debarment requirements at 2 CFR parts 180 and 376.
In accordance 41 U.S.C. 2313, CDC is required to review the non-public segment of the OMB-designated integrity and performance system accessible through SAM (currently the Federal Awardee Performance and Integrity Information System (FAPIIS)) prior to making a Federal award where the Federal share is expected to exceed the simplified acquisition threshold, defined in 41 U.S.C. 134, over the period of performance. At a minimum, the information in the system for a prior Federal award recipient must demonstrate a satisfactory record of executing programs or activities under Federal grants, cooperative agreements, or procurement awards; and integrity and business ethics. CDC may make a Federal award to a recipient who does not fully meet these standards, if it is determined that the information is not relevant to the current Federal award under consideration or there are specific conditions that can appropriately mitigate the effects of the non-Federal entity's risk in accordance with 45 CFR §75.207.
CDC’s framework for evaluating the risks posed by an applicant may incorporate results of the evaluation of the applicant's eligibility or the quality of its application. If it is determined that a Federal award will be made, special conditions that correspond to the degree of risk assessed may be applied to the Federal award. In evaluating risks posed by applicants, CDC will use a risk-based approach and may consider any items such as the following:
CDC must comply with the guidelines on government-wide suspension and debarment in 2 CFR Part 180 and require non-Federal entities to comply with these provisions. These provisions restrict Federal awards, subawards and contracts with certain parties that are debarred, suspended or otherwise excluded from or ineligible for participation in Federal programs or activities.
ARs outline the administrative requirements found in 45 CFR Part 75, the HHS Grants Policy Statement , and other requirements as mandated by statute or CDC policy. Recipients must comply with administrative and national policy requirements as appropriate. For more information on the Code of Federal Regulations, visit the National Archives and Records Administration.
Information on additional requirements that apply to this FOA can be found at the following CDC website https://www.cdc.gov/grants/additionalrequirements/.
Generally applicable ARs are:
Organization specific ARs are:
The following are additional policy requirements relevant to this FOA.
HHS Policy on Promoting Efficient Spending: Use of Appropriated Funds for Conferences and Meetings, Food, Promotional Items and Printing Publications
This policy supports the Executive Order on Promoting Efficient Spending (EO 13589), the Executive Order on Delivering and Efficient, Effective, and Accountable Government (EO 13576) and the Office of Management and Budget Memorandum on Eliminating Excess Conference Spending and Promoting Efficiency in Government (M-35-11). This policy applies to all new obligations and all funds appropriated by Congress. For more information, visit the HHS website at HHS Policy on Promoting Efficient Spending.
Federal Funding Accountability and Transparency Act of 2006
Federal Funding Accountability and Transparency Act of 2006 (FFATA), P.L. 109–282, as amended by section 6202 of P.L. 110–252, requires full disclosure of all entities and organizations receiving Federal funds including grants, contracts, loans and other assistance and payments through a single, publicly accessible website, http://www.usaspending.gov/. For the full text of the requirements, please review the following website: https://www.fsrs.gov/.
Plain Writing Act
The Plain Writing Act of 2010, Public Law 111-274 was signed into law on October 13, 2010. The law requires that federal agencies use "clear Government communication that the public can understand and use" and requires the federal government to write all new publications, forms, and publicly distributed documents in a "clear, concise, well-organized" manner. For more information on this law, go to: https://plainlanguage.gov/law/.
Tobacco and Nutrition Policies
The CDC supports implementing evidence-based programs and policies to reduce tobacco use and secondhand smoke exposure, and to promote healthy nutrition. CDC encourages all awardees to implement the following optional evidence-based tobacco and nutrition policies within their organizations. These policies build on the current federal commitment to reduce exposure to secondhand smoke, which includes The Pro-Children Act, 20 U.S.C. 7181-7184 that prohibits smoking in certain facilities that receive federal funds.
Tobacco-free indoors – no use of any tobacco products (including smokeless tobacco) or electronic cigarettes in any indoor facilities under the control of the applicant.
Tobacco-free indoors and in adjacent outdoor areas – no use of any tobacco products or electronic cigarettes in any indoor facilities, within 50 feet of doorways and air intake ducts, and in courtyards under the control of the applicant.
Tobacco-free campus – no use of any tobacco products or electronic cigarettes in any indoor facilities and anywhere on grounds or in outdoor space under the control of the applicant.
Healthy food service guidelines that at a minimum align with Health and Human Services and General Services Administration Health and Sustainability Guidelines for Federal Concessions and Vending Operations for cafeterias, snack bars, and vending machines in any facility under the control of the recipient organization and in accordance with contractual obligations for these services. The following are resources for healthy eating and tobacco free workplaces:
Applicants should state whether they choose to participate in implementing these two optional policies. However, no applicants will be evaluated or scored on whether they choose to participate in implementing these optional policies.
Pilot Program for Enhancement of Employee Whistleblower Protections
All applicants will be subject to a term and condition that applies the terms of 48 CFR section 3.908 to the award and requires that grantees inform their employees in writing (in the predominant native language of the workforce) of employee whistleblower rights and protections under 41 U.S.C. 4712.
Copyright Interests Provision
This provision is intended to ensure that the public has access to the results and accomplishments of public health activities funded by CDC. Pursuant to applicable grant regulations and CDC’s Public Access Policy, Recipient agrees to submit into the National Institutes of Health (NIH) Manuscript Submission (NIHMS) system an electronic version of the final, peer-reviewed manuscript of any such work developed under this award upon acceptance for publication, to be made publicly available no later than 12 months after the official date of publication. Also, at the time of submission, Recipient and/or the Recipient’s submitting author must specify the date the final manuscript will be publicly accessible through PubMed Central (PMC). Recipient and/or Recipient’s submitting author must also post the manuscript through PMC within twelve (12) months of the publisher's official date of final publication; however, the author is strongly encouraged to make the subject manuscript available as soon as possible. The recipient must obtain prior approval from the CDC for any exception to this provision.
The author's final, peer-reviewed manuscript is defined as the final version accepted for journal publication and includes all modifications from the publishing peer review process, and all graphics and supplemental material associated with the article. Recipient and its submitting authors working under this award are responsible for ensuring that any publishing or copyright agreements concerning submitted articles reserve adequate right to fully comply with this provision and the license reserved by CDC. The manuscript will be hosted in both PMC and the CDC Stacks institutional repository system. In progress reports for this award, recipient must identify publications subject to the CDC Public Access Policy by using the applicable NIHMS identification number for up to three (3) months after the publication date and the PubMed Central identification number (PMCID) thereafter.
Language Access for Persons with Limited English Proficiency
Recipients of federal financial assistance from HHS must administer their programs in compliance with federal civil rights law. This means that recipients of HHS funds must ensure equal access to their programs without regard to a person’s race, color, national origin, disability, age and, in some circumstances, sex and religion. This includes ensuring your programs are accessible to persons with limited English proficiency. Recipients of federal financial assistance must take the reasonable steps to provide meaningful access to their programs by persons with limited English proficiency.
Dual Use Research of Concern
On September 24, 2014, the US Government Policy (USG) for the Institutional Oversight of Life Sciences Dual Use Research of Concern was released. Grantees (foreign and domestic) receiving CDC funding on or after September 24, 2015 are subject to this policy. Research funded by CDC involving the agents or toxins named in the policy, must be reviewed to determine if it involves one or more of the listed experimental effects and if so, whether it meets the definition of DURC. This review must be completed by an Institutional Review Entity (IRE) identified by the funded institution.
Recipients also must establish an Institutional Contact for Dual Use Research (ICDUR). The award recipient must maintain records of institutional DURC reviews and completed risk mitigation plans for the term of the research grant, cooperative agreement or contract plus three years after its completion, but no less than eight years, unless a shorter period is required by law or regulation.
If a project is determined to be DURC, a risk/benefit analysis must be completed. CDC will work collaboratively with the award recipient to develop a risk mitigation plan that the CDC must approve. The USG policy can be found at https://www.phe.gov/s3/dualuse/Pages/default.aspx.
Non-compliance with this Policy may result in suspension, limitation, restriction or termination of USG funding, or loss of future USG funding opportunities for the non-compliant USG-funded research project and of USG funds for other life sciences research at the institution, consistent with existing regulations and policies governing USG funded research, and may subject the institution to other potential penalties under applicable laws and regulations.
Federal Information Security Management Act
All information systems, electronic or hard copy which contain Federal data need to be protected from unauthorized access. This also applies to information associated with NIOSH grants and contracts. Congress and the OMB have instituted laws, policies and directives that govern the creation and implementation of federal information security practices that pertain specifically to grants and contracts. The current regulations are pursuant to the Federal Information Security Management Act (FISMA), 44 U.S.C. 3541 et seq. The applicability of FISMA to NIOSH recipient applies only when recipients collect, store, process, transmit or use information on behalf of HHS or any of its component organizations. In all other cases, FISMA is not applicable to recipients of grants, including cooperative agreements. The recipient retains the original data and intellectual property, and is responsible for the security of this data, subject to all applicable laws protecting security, privacy, and research. When information collected by a recipient is provided to HHS, responsibility for the protection of the HHS copy of the information is transferred to HHS and it becomes the agency's responsibility to protect that information and any derivative copies as required by FISMA.
Cooperative Agreement Terms and Conditions of Award
The following special terms of award are in addition to, and not in lieu of, otherwise applicable U.S. Office of Management and Budget (OMB) administrative guidelines, U.S. Department of Health and Human Services (HHS) grant administration regulations at 45 CFR Parts 74 and 92 (Part 92 is applicable when state and local governments are eligible to apply), and other HHS, PHS, and CDC rant administration policies.
The administrative and funding instrument used for this program will be the cooperative agreement, an “assistance” mechanism (rather than an “acquisition” mechanism), in which substantial CDC programmatic involvement with the awardees is anticipated during the performance of the activities. Under the cooperative agreement, the HHS/CDC purpose is to support and stimulate the recipients’ activities by involvement and otherwise working jointly with the award recipients in a partnership role; it is not to assume direction, prime responsibility, or a dominant role in the activities. Consistent with this concept, the dominant role and prime responsibility resides with the awardees for the project, although specific tasks and activities may be shared among the awardees and HHS/CDC as defined below.
Awardees will retain custody of and have primary rights to the data and software developed under these awards, subject to government rights of access consistent with current HHS, PHS, and CDC policies.
NIOSH staff with relevant subject matter expertise may have substantial programmatic involvement that is above and beyond the normal stewardship role in awards. These include, but are not limited to, these activities:
Specific substantial involvement activities for NIOSH project scientists will be negotiated further with each grantee as part of the pre-award process. This will include adding special terms and conditions in the NOA.
NIOSH Program Official (PO)
Additionally, the Scientific/Research Contact named in this announcement will serve as the Program Official (PO) for all awards. This person will be responsible for the normal scientific and programmatic stewardship of these awards and will be named in the NOAs. The PO will have programmatic involvement during the conduct of this activity through approval of progress reports, human subjects' protection, and advice and coordination commensurate with normal program stewardship for grants. Other PO responsibilities include these:
Areas of Joint Responsibility
Responsibilities are divided between awardees and NIOSH staff as described above. Substantial involvement responsibilities of NIOSH project scientists will be collaborative, consultative, and facilitative, not proscriptive, in nature.
Any disagreements that may arise in scientific or programmatic matters (within the scope of the award) between award recipients and NIOSH may be brought to Dispute Resolution. A Dispute Resolution Panel will be convened and will have three members: a designee of the awardee, a NIOSH designee, and a designee with expertise in the relevant area who is chosen by the other two. This special dispute resolution procedure does not alter the awardee's right to appeal an adverse action that is otherwise appealable in accordance with PHS regulations 42 CFR Part 50, Subpart D, and HHS regulations 45 CFR Part 16.
Recipients are expected to attend and include funds in their annual budgets for two representatives, including the PI or designee, to attend two NIOSH-convened grantee (Partner) meetings per year (may be in person or virtual). These one-day meetings will be organized and convened by NIOSH officials with input from the grantees and others. One of these meetings will be held each November-December, usually in conjunction with the CSTE Occupational Health Subcommittee meeting. Another meeting will possibly coincide with the CSTE Annual Conference (typically in June) during which grantees attend the OSH sessions at the CSTE Conference. For budget preparation for all years of requested support, assume the November-December meeting will be held in Washington D.C. and the June meeting in Denver, CO unless notified otherwise.
In addition to the meetings described above, applicants for the FACE program must budget for up to two personnel to attend a two-day annual meeting. Applicants for the pesticide illness related project should budget for one person to attend an annual one and one-half day meeting. Applicants for the work-related lung/respiratory project are expected to attend an annual two-and one-half day meeting for up to two people. For budget preparation, assume these meetings will be held in Washington D.C. unless specified otherwise.
Note for budget preparation: An applicant may not propose use of grant funds to host and expend funds for a rented venue for a regional or multi-state scientific meeting or conference without a prior approval from CDC NIOSH.
CDC Grantee SAS Statistic Software Licenses
Note for budget preparation: An applicant may also request a reduced-cost CDC grantee SAS statistical software license. However, only one SAS PC-compatible base-type license per program and Expanded Project may be requested, subject to CDC availability and policy and based on availability of funds. If the license(s) application is approved by CDC, NIOSH will reduce (offset) the annual award amount by the cost of the SAS license(s). Allow 1-2 months for CDC processing of a state request, immediately after award, in coordination with the CDC SAS support program. Reduction of Award funds may vary by year over the grant 5-year project period due to possible fluctuation in annual SAS license cost.
When multiple years are involved, awardees will be required to submit the Research Performance Progress Report (RPPR) annually and financial statements as required in the HHS Grants Policy Statement. Program staff will evaluate the effectiveness of resource sharing as part of the administrative review of each Non-Competing Continuation Grant Progress Report.
A final progress report, invention statement, and the expenditure data portion of the Federal Financial Report are required for closeout of an award, as described in the HHS Grants Policy Statement.
The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for awardees of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. Compliance with this law is primarily the responsibility of the Federal agency. However, two elements of the law require information to be collected and reported by awardees: 1) information on executive compensation when not already reported through the SAM Registration; and 2) similar information on all sub-awards/ subcontracts/ consortiums over $25,000. All awardees of applicable CDC grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) on all subawards over $25,000. See the HHS Grants Policy Statement for additional information on this reporting requirement.
In accordance with the regulatory requirements provided at 45 CFR 75.113 and Appendix XII to 45 CFR Part 75, recipients that have currently active Federal grants, cooperative agreements, and procurement contracts from all Federal awarding agencies with a cumulative total value greater than $10,000,000 for any period of time during the period of performance of a Federal award, must report and maintain the currency of information reported in the System for Award Management (SAM) about civil, criminal, and administrative proceedings in connection with the award or performance of a Federal award that reached final disposition within the most recent five-year period.
The recipient must also make semiannual disclosures regarding such proceedings. Proceedings information will be made publicly available in the designated integrity and performance system (currently FAPIIS). This is a statutory requirement under section 872 of Public Law 110-417, as amended (41 U.S.C. 2313). As required by section 3010 of Public Law 111-212, all information posted in the designated integrity and performance system on or after April 15, 2011, except past performance reviews required for Federal procurement contracts, will be publicly available. Full reporting requirements and procedures are found in Appendix XII to 45 CFR Part 75 – Award Term and Conditions for Recipient Integrity and Performance Matters.
Annual Report of Major Outputs, Accomplishments and Outcomes. The report will be written in a style and semi technical content for uptake by professionals. A 5-page PDF-type page limit each will apply for all three types of Programs and for each Expanded Projects and should include a page for outcomes and outputs such as publications, citations, and other product descriptions. An additional 2 pages will be allowed for two success stories (one page maximum each) that can be utilized by NIOSH or CSTE. NIOSH will select 6-8 success stories to feature for their yearly NIOSH/Office of Extramural Programs Annual Report, or to feature throughout the year in their eNews or Research Rounds features. The PD/PI is fully responsible for its content, and NIOSH does not intend to substantially edit the submission. including a page for publications, citations and other product descriptions. The author is fully responsible for its content, and NIOSH does not intend to substantially proof or edit the submission. NIOSH may post the report on its website for public viewing. This report will be due typically in mid-August each year.
Evaluation and Performance Management should be discussed along with evaluation results.
The Recipient Organization must provide HHS/CDC with an original, plus one hard copy of the following reports:
1. Yearly Non-Competing Grant Progress Report. The RPPR is due 90 to 120 days prior to the end of the current budget period and is to be completed on the eRA Commons website. The progress report will serve as the non-competing continuation application. Although the financial plans of the HHS/CDC CIO(s) provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds, evidence of satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.
2. Annual Federal Financial Report (FFR) SF 425 is required and must be submitted through eRA Commons within 90 days after the end of the calendar quarter in which the budget period ends.
3. A final progress report, invention statement, equipment/inventory report, and the final FFR are required 90 days after the end of the project period.
1. Yearly Non-Competing Grant Progress Report
The grantee’s continuation application/progress report should include:
Research Aim/Project: purpose, status (met, ongoing, and unmet), challenges, successes, and lessons learned.
Leadership/Partnership: list project collaborations and describe the role of external partners.
How will scientific findings be translated into public health practice or inform public health policy?
How will the project improve or effect the translation of research findings into public health practice or inform policy?
How will the research findings help promote or accelerate the dissemination, implementation, or diffusion of improvements in public health programs or practices?
How will the findings advance or guide future research efforts or related activities?
How will this project lead to improvements in public health?
How will the findings, results, or recommendations been used to influence practices, procedures, methodologies, etc.?
How will the findings, results, or recommendations contribute to documented or projected reductions in morbidity, mortality, injury, disability, or disease?
2. Annual Federal Financial Reporting
The Annual Federal Financial Report (FFR) SF 425 is required and must be submitted through eRA Commons within 90 days after the end of the calendar quarter in which the budget period ends. The FFR should only include those funds authorized and disbursed during the timeframe covered by the report. The final FFR must indicate the exact balance of unobligated funds and may not reflect any unliquidated obligations. There must be no discrepancies between the final FFR expenditure data and the Payment Management System's (PMS) cash transaction data.
Failure to submit the required information in a timely manner may adversely affect the future funding of this project. If the information cannot be provided by the due date, you are required to submit a letter explaining the reason and date by which the Grants Officer will receive the information. The due date for final FFRs will continue to be 90 days after the Period of Performance end date.
Grantees must submit closeout reports in a timely manner. Unless the Grants Management Officer (GMO) of the awarding Institute or Center approves an extension, grantees must submit a final FFR, final progress report, and Final Invention Statement and Certification within 90 days of the end of grant period. Failure to submit timely and accurate final reports may affect future funding to the organization or awards under the direction of the same Project Director/Principal Investigator (PD/PI).
FFR (SF 425) instructions for CDC grantees are now available at NIH Forms Library. For further information, contact GrantsInfo@nih.gov. Additional resources concerning the eFSR/FFR system, including a User Guide and an on-line demonstration, can be found on the eRA Commons Support Page.
FFR Submission: The submission of FFRs to CDC will require organizations to register with eRA Commons (Commons). CDC recommends that this one-time registration process be completed at least 2 weeks prior to the submittal date of an FFR submission.
Organizations may verify their current registration status by running the “List of Commons Registered Organizations” query found at: eRA Common Registration & Accounts. Organizations not yet registered can go to Welcome to the Commons for instructions. It generally takes several days to complete this registration process. This registration is independent of Grants.gov and may be done at any time.
The individual designated as the PI on the application must also be registered in the Commons. The PI must hold a PI account and be affiliated with the applicant organization. This registration must be done by an organizational official or their delegate who is already registered in the Commons. To register PIs in the Commons, refer to the eRA Commons User Guide found at: Overview of the eRA Commons.
3. Final Reports
Final reports should provide enough detail for CDC to determine if the stated outcomes for the funded research have been achieved and if the research findings resulted in public health impact based on the investment.
Specific guidance for the final report and annual outcome update is available on the NIOSH OEP website under Grant Closeout.
We encourage inquiries concerning this funding opportunity
and welcome the opportunity to answer questions from potential applicants.
eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date, and post-submission issues)
Finding Help Online: http://grants.nih.gov/support/ (preferred
method of contact)
Telephone: 301-402-7469 or 866-504-9552 (Toll Free)
General Grants Information
(Questions regarding application instructions, application processes, and NIH
Email: GrantsInfo@nih.gov (preferred method of contact)
Grants.gov Customer Support (Questions regarding Grants.gov
registration and Workspace)
Contact Center Telephone: 800-518-4726
CAPT Linda West, MSPH, USPHS
Scientific Program Official
National Institute for Occupational Safety and Health (NIOSH)
Centers for Disease Control and Prevention (CDC)
Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).
Questions regarding peer review may sent to:
Michael Goldcamp, PhD
Scientific Review Official
National Institute for Occupational Safety and Health (NIOSH)
Centers for Disease Control and Prevention (CDC)
Ferrinnia (Toni) Augustus-High, MSA, CGMS
Grants Management Specialist
Office of Grants Services (OGS)
Office of Financial Resources (OFR)
Office of the Chief Operating Officer (OCOO)
Centers for Disease Control and Prevention (CDC)
Other CDC funding opportunity announcements can be found at www.grants.gov. Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
This program is described in the Catalog of Federal Domestic Assistance and is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency Review. Awards are made under the authorization of the Occupational Safety and Health Act of 1970, Section 20(a) and 21(a) (29 USC 669(a) and 29 USC 670); Federal Mine Safety and Health Act, Section 501(a), 30 USC 1 (Note), and 30 USC 951(a); and Section 301 of the Public Health Service Act as amended (42 USC 241) and under Federal Regulations 42 CFR Part 52. All awards are subject to 45 CFR Part 75, the terms and conditions, and other considerations described in the HHS Grants Policy Statement.
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.